Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
12 September 2014
Header
Header image
From our blog

From our blog

Highlights from the Annual Congress of International Pharmaceutical Federation in Bangkok
12 September 2014 by Sini Eskola

This year 1,938 pharmacists and pharmaceutical scientists from 95 countries across the globe gathered in Bangkok in the FIP Annual Congress from 29 Aug to 4 September. This year’s Congress ran under the theme “Access to medicines and pharmacists today, better outcomes tomorrow”. I was lucky enough to be among those from EFPIA taking part in FIP and wanted to share some highlights of the week below.

Read more

Events calendar

Events Calendar

Health Driving Growth
On 15/10/2014 (Brussels, Belgium)

On 15 October 2014, EFPIA will host a public conference to discuss the best path towards a stronger healthier and more prosperous EU. #HealthyEU – Health Driving [...] Read more

What we are reading

What we are reading

Ebolanomics
08 September 2014

The deadly hemorrhagic fever Ebola was first discovered in 1976, and it has haunted the public imagination for twenty years, ever since the publication of Richard Preston’s “The Hot Zone.” Yet, in all that time, no drug has ever been approved to treat the disease. Now the deadliest outbreak yet is raging in West Africa, and there are no real tools to stop it. 

Read more

What we are reading

@MHRA: regulators could track #drug reactions via Twitter
12 September 2014

The UK Medicines and Healthcare products Regulatory Agency (MHRA) says Twitter, Facebook and smartphone apps could soon be used to gather adverse drug reactions (ADRs)

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail